Regeneron Pharmaceuticals, Inc. is dhaafsi kaydka in dollars taariikhda qiimaha, shaxanka waayo, November 2018
Qodobbada saamiyada Regeneron Pharmaceuticals, Inc. ee November 2018 ayaa isbeddelay ilaa +2.97%. Qiimaha ugu hooseeya saamiyada Regeneron Pharmaceuticals, Inc. ee November 2018 wuxuu ahaa 337.29 US dollar. Qiimaha ugu sarreeya saamiyada REGN ee November 2018 wuxuu ahaa 365.65 US dollar.
Muuji:
Regeneron Pharmaceuticals, Inc. (REGN)
In
US dollar (USD)
Regeneron Pharmaceuticals, Inc. US dollar qiimaha taariikhda
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
August 2005
July 2005
June 2005
May 2005
April 2005
March 2005
February 2005
January 2005
December 2004
November 2004
October 2004
September 2004
August 2004
July 2004
June 2004
May 2004
April 2004
March 2004
February 2004
January 2004
December 2003
November 2003
October 2003
September 2003
August 2003
July 2003
June 2003
May 2003
April 2003
March 2003
February 2003
January 2003
December 2002
November 2002
October 2002
September 2002
August 2002
July 2002
June 2002
May 2002
April 2002
March 2002
February 2002
January 2002
December 2001
November 2001
October 2001
September 2001
August 2001
July 2001
June 2001
May 2001
April 2001
March 2001
February 2001
January 2001
December 2000
November 2000
October 2000
September 2000
August 2000
July 2000
June 2000
May 2000
April 2000
March 2000
February 2000
January 2000
December 1999
November 1999
October 1999
September 1999
August 1999
July 1999
June 1999
May 1999
April 1999
March 1999
February 1999
January 1999
December 1998
November 1998
October 1998
September 1998
August 1998
July 1998
June 1998
May 1998
April 1998
March 1998
February 1998
January 1998
December 1997
November 1997
October 1997
September 1997
August 1997
July 1997
June 1997
May 1997
April 1997
March 1997
February 1997
January 1997
December 1996
November 1996
October 1996
September 1996
August 1996
July 1996
June 1996
May 1996
April 1996
March 1996
February 1996
January 1996
December 1995
November 1995
October 1995
September 1995
August 1995
July 1995
June 1995
May 1995
April 1995
March 1995
February 1995
January 1995
December 1994
November 1994
October 1994
September 1994
August 1994
July 1994
June 1994
May 1994
April 1994
March 1994
February 1994
January 1994
December 1993
November 1993
October 1993
September 1993
August 1993
July 1993
June 1993
May 1993
April 1993
March 1993
February 1993
January 1993
December 1992
November 1992
October 1992
September 1992
August 1992
July 1992
June 1992
May 1992
April 1992
March 1992
February 1992
January 1992
December 1991
November 1991
October 1991
September 1991
August 1991
July 1991
June 1991
May 1991
April 1991
Taariikhda
Rate
30/11/2018
365.65 USD
29/11/2018
359.57 USD
28/11/2018
363.64 USD
27/11/2018
353.59 USD
26/11/2018
353.18 USD
23/11/2018
340.86 USD
21/11/2018
343.17 USD
20/11/2018
337.29 USD
19/11/2018
338.99 USD
16/11/2018
345.33 USD
15/11/2018
341.65 USD
14/11/2018
337.29 USD
13/11/2018
342.1 USD
12/11/2018
346.56 USD
09/11/2018
356.66 USD
08/11/2018
363.34 USD
07/11/2018
364.25 USD
06/11/2018
357.61 USD
05/11/2018
354.93 USD
02/11/2018
352.59 USD
01/11/2018
355.11 USD
Kharashka saamiyada Regeneron Pharmaceuticals, Inc.
Qiimaha REGN online
Regeneron Pharmaceuticals, Inc. saamiyada dhabta ah ee waqtiga, REGN qiimaha saamiga online, REGN.
Qiimaha REGN online
Maaliyadda Regeneron Pharmaceuticals, Inc.
Dakhliga Regeneron Pharmaceuticals, Inc.
Ka warbixi natiijooyinka dhaqaale ee shirkadda Regeneron Pharmaceuticals, Inc., dakhliga sanadlaha ee Regeneron Pharmaceuticals, Inc. ee 2024.
Dakhliga Regeneron Pharmaceuticals, Inc.
